MyFinsight
Home
Blog
About
Contact
Download
Download image
US
$1,534M
(-19.69%↓ Y/Y)
Europe
$1,340M
(12.23%↑ Y/Y)
Other Activities
$584M
(183.50%↑ Y/Y)
International Markets
$524M
(-9.97%↓ Y/Y)
Net revenues
$3,982M
(2.34%↑ Y/Y)
Gross profit
$1,972M
(5.06%↑ Y/Y)
Other loss (income)
$9M
(280.00%↑ Y/Y)
Cost of sales
$2,011M
(-0.15%↓ Y/Y)
Operating income (loss)
$652M
(25.63%↑ Y/Y)
Selling and marketing
expenses
$696M
(11.90%↑ Y/Y)
General and
administrative expenses
$304M
(2.36%↑ Y/Y)
Research and development
expenses
$222M
(-10.12%↓ Y/Y)
Legal settlements and
loss contingencies
$72M
(-16.28%↓ Y/Y)
Other assets
impairments, restructuring...
$26M
(218.18%↑ Y/Y)
Intangible assets
impairments
$8M
(-93.39%↓ Y/Y)
Income (gain) before
income taxes
$437M
(48.64%↑ Y/Y)
Financial expenses, net
-$216M
(4.00%↑ Y/Y)
Net income (loss)
$369M
(67.73%↑ Y/Y)
Income taxes (benefit)
$67M
(-9.46%↓ Y/Y)
Share in (profits)
losses of associated...
-$1M
Net income (loss)
attributable to teva
$369M
(72.43%↑ Y/Y)
Back
Back
Income Statement
logo_teva-svg
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
logo_teva-svg
source: myfinsight.com
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)